| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/17/2001 | US6262057 Pseudopolymorphic forms of 2-[2-[4-[Bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride |
| 07/17/2001 | US6262046 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 07/17/2001 | US6262040 Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the production of tumor necrosis factor (TNF) |
| 07/17/2001 | US6262016 Transferrin receptor genes |
| 07/17/2001 | US6261817 Guaa |
| 07/17/2001 | US6261801 Nucleic acids encoding tumor necrosis factor receptor 5 |
| 07/17/2001 | US6261799 Expression cassettes encoding soluble, non-cleavable, chimeric HIV-1 GP160 variants, their methods of construction, and methods for the production of GP160 variants |
| 07/17/2001 | US6261573 Mixture of antigen, water soluble polymer and amphiphilic compounds |
| 07/17/2001 | US6261571 Immunogenic compositions comprising dimeric forms of the human immunodeficiency virus type 2 (HIV-2) and simian immunodeficiency virus (SIV) envelope glycoproteins |
| 07/17/2001 | US6261568 Genetic engineering |
| 07/17/2001 | US6261562 Compounds for immunotherapy of prostate cancer and methods for their use |
| 07/17/2001 | US6261561 Administering intimin or fusion protein |
| 07/17/2001 | US6261281 Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells |
| 07/17/2001 | CA2223023C N-hydroxyureas as antiinflammatory agents |
| 07/17/2001 | CA2160961C New tricyclic amide compounds, process for preparing the same and pharmaceutical compositions containing them |
| 07/17/2001 | CA2151141C Mammalian receptors for interleukin-10 (il-10) |
| 07/17/2001 | CA2104225C Method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases |
| 07/17/2001 | CA2055615C Monoclonal antibodies for inducing tolerance |
| 07/17/2001 | CA2034197C Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus |
| 07/12/2001 | WO2001049866A1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 07/12/2001 | WO2001049825A1 Methods for protein transfer |
| 07/12/2001 | WO2001049743A2 Methods of modulation of the immune system |
| 07/12/2001 | WO2001049739A1 A new polypeptide-myelin p0 protein 14 and the polynucleotide encoding it |
| 07/12/2001 | WO2001049736A1 A new polypeptide-human rs3 protein and the polynucleotide encoding it |
| 07/12/2001 | WO2001049731A1 A new polypeptide-human protease regulatory protein 9 and the polynucleotide encoding it |
| 07/12/2001 | WO2001049717A2 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or t cell subset activity by modulation of xbp-1 activity |
| 07/12/2001 | WO2001049713A2 Stabilizing peptides, polypeptides and antibodies which include them |
| 07/12/2001 | WO2001049711A2 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | WO2001049705A2 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent |
| 07/12/2001 | WO2001049698A1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use |
| 07/12/2001 | WO2001049689A2 NOVEL SUBSTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM |
| 07/12/2001 | WO2001049688A1 Purine derivatives, process for their preparation and use thereof |
| 07/12/2001 | WO2001049685A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 07/12/2001 | WO2001049684A1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 07/12/2001 | WO2001049676A1 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof |
| 07/12/2001 | WO2001049673A2 Compounds and methods for modulation of estrogen receptors |
| 07/12/2001 | WO2001049661A1 5-THIA-φ-(SUBSTITUTED PHENYL)-PROSTAGLANDIN E ALCOHOLS, PROCESS FOR PREPARING THE ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT |
| 07/12/2001 | WO2001049657A1 2-`3-amino-4-(n-hydroxyamino)-succinylamino-acetamides for use as cd23 formation inhibitors |
| 07/12/2001 | WO2001049654A2 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 07/12/2001 | WO2001049651A2 Aminomethyl-phenyl-cyclohexanone derivatives |
| 07/12/2001 | WO2001049323A1 Combination therapy for the treatment of inflammatory and respiratory diseases |
| 07/12/2001 | WO2001049320A2 Use of hemicellulose microparticles as vaccine adjuvant |
| 07/12/2001 | WO2001049319A1 Composition containing bacterial antigens, used for the prophylaxis and the treatment of allergic diseases |
| 07/12/2001 | WO2001049318A1 Novel chimeric proteins and methods for using the same |
| 07/12/2001 | WO2001049317A2 Enhancing the immune response to an antigen by presensitizing with an inducing agent prior to immunizing with the inducing agent and the antigen |
| 07/12/2001 | WO2001049313A1 Use of ngf for the manufacturing of a drug for treating allergic disorders |
| 07/12/2001 | WO2001049312A2 O-superfamily conotoxin peptides |
| 07/12/2001 | WO2001049311A1 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release |
| 07/12/2001 | WO2001049308A1 Novel immune enhancing compositions |
| 07/12/2001 | WO2001049305A2 Process for obtaining thylakoids from plants, pure thylakoids and use thereof |
| 07/12/2001 | WO2001049303A1 Multivalent electron active compositions and methods of making and using same |
| 07/12/2001 | WO2001049302A1 Compositions and methods for facilitating skin growth and managing skin conditions |
| 07/12/2001 | WO2001049301A1 Methods of using electron active compounds for managing cancer |
| 07/12/2001 | WO2001049287A1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 07/12/2001 | WO2001049277A2 Immune response modulation |
| 07/12/2001 | WO2001049163A1 Pp14 fusion proteins and methods for making and using the same |
| 07/12/2001 | WO2001012665A3 Helical cytokine zalpha48 |
| 07/12/2001 | WO2000074724A3 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |
| 07/12/2001 | WO2000063361A3 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides |
| 07/12/2001 | WO2000034447A8 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 07/12/2001 | WO2000032205A9 Immunomodulatory methods using carbohydrate antigens |
| 07/12/2001 | WO2000005223A3 Heterocyclic derivatives and their use as integrin inhibitors |
| 07/12/2001 | US20010007758 Administering mixture of synthetic polypeptides |
| 07/12/2001 | US20010007755 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 07/12/2001 | US20010007693 Food products having enhanced cocoa polyphenol content and processes for producing the same |
| 07/12/2001 | US20010007680 Use of a film coating as taste-masking coating of oral dosage forms |
| 07/12/2001 | DE19963868A1 Neue substituierte Piperidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung New substituted piperidines, pharmaceutical compositions containing them and methods for their preparation |
| 07/12/2001 | DE19963859A1 Bi- oder Oligomer eines Di-, Tri-, Quattro- oder Pentamers von rekombinanten Fusionsproteinen Bi- or oligomer of a di-, tri-, Quattro or pentamer of recombinant fusion proteins |
| 07/12/2001 | DE19963179A1 Substituierte 1- und 2-Naphthol-Mannichbasen Substituted 1- and 2-naphthol Mannich bases |
| 07/12/2001 | DE19963174A1 Substituierte Pyrrol-Mannichbasen Substituted pyrrole Mannich bases |
| 07/12/2001 | DE19962828A1 Screeningsverfahren für Chemotherapeutika Screening method for chemotherapeutic agents |
| 07/12/2001 | DE10000312A1 Substituierte Aminomethyl-Phenyl-Cyclohexanderivate Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 07/12/2001 | DE10000311A1 Aminomethyl-Phonyl-Cyclohexanonderivate Aminomethyl-Phonyl-cyclohexanone derivatives |
| 07/12/2001 | CA2397714A1 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent |
| 07/12/2001 | CA2396529A1 O-superfamily conotoxin peptides |
| 07/12/2001 | CA2396399A1 Methods for protein transfer |
| 07/12/2001 | CA2396315A1 Novel substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them |
| 07/12/2001 | CA2396310A1 Aminomethyl-phenyl-cyclohexanone derivatives |
| 07/12/2001 | CA2396304A1 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 07/12/2001 | CA2396276A1 Purine derivatives, process for their preparation and use thereof |
| 07/12/2001 | CA2396239A1 Novel immune enhancing compositions |
| 07/12/2001 | CA2396114A1 Methods of modulation of the immune system |
| 07/12/2001 | CA2396059A1 Compounds and methods for modulation of estrogen receptors |
| 07/12/2001 | CA2395945A1 Novel chimeric proteins and methods for using the same |
| 07/12/2001 | CA2395892A1 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release |
| 07/12/2001 | CA2395876A1 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | CA2395660A1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use |
| 07/12/2001 | CA2395198A1 Pp14 fusion proteins and methods for making and using the same |
| 07/12/2001 | CA2395041A1 Stabilizing peptides, polypeptides and antibodies which include them |
| 07/12/2001 | CA2394597A1 Enhancing the immune response to an antigen by presensitizing with an inducing agent prior to immunizing with the inducing agent and the antigen |
| 07/11/2001 | EP1114829A2 Alloferons - Immunomodulatory peptides |
| 07/11/2001 | EP1114823A2 Substituted benzylamino nitrogen containing non-aromatic heterocycles |
| 07/11/2001 | EP1114164A1 Atp synthase subunit homolog |
| 07/11/2001 | EP1114159A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 07/11/2001 | EP1114158A2 Human cytoskeleton associated proteins |
| 07/11/2001 | EP1114155A2 Human gpcr proteins |
| 07/11/2001 | EP1114146A2 Human serine/threonine protein kinases |
| 07/11/2001 | EP1114063A2 A method of producing a functional immunoglobulin superfamily protein |
| 07/11/2001 | EP1114053A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 07/11/2001 | EP1114052A1 4-aminopyrrolopyrimidines as kinase inhibitors |